Dangle
发表于 2025-3-21 19:25:01
书目名称Drug Adherence in Hypertension and Cardiovascular Protection影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0283029<br><br> <br><br>书目名称Drug Adherence in Hypertension and Cardiovascular Protection影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0283029<br><br> <br><br>书目名称Drug Adherence in Hypertension and Cardiovascular Protection网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0283029<br><br> <br><br>书目名称Drug Adherence in Hypertension and Cardiovascular Protection网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0283029<br><br> <br><br>书目名称Drug Adherence in Hypertension and Cardiovascular Protection被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0283029<br><br> <br><br>书目名称Drug Adherence in Hypertension and Cardiovascular Protection被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0283029<br><br> <br><br>书目名称Drug Adherence in Hypertension and Cardiovascular Protection年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0283029<br><br> <br><br>书目名称Drug Adherence in Hypertension and Cardiovascular Protection年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0283029<br><br> <br><br>书目名称Drug Adherence in Hypertension and Cardiovascular Protection读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0283029<br><br> <br><br>书目名称Drug Adherence in Hypertension and Cardiovascular Protection读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0283029<br><br> <br><br>
Astigmatism
发表于 2025-3-21 21:53:16
https://doi.org/10.1007/978-3-662-24745-7ons and a maximum of 2 hours of post-DOT-HTN observation. Three reports had longer observation time, two of them with medication administration intervals, and blood pressure measurement intervals. Two were case reports, describing severe post-DOT-HTN adverse reactions, contributing with important sa
irritation
发表于 2025-3-22 01:12:59
https://doi.org/10.1007/978-3-662-24745-7 cannot be assessed this way. These uncertainties reduce the value of biochemical monitoring. Biochemical monitoring of adherence should be preceded by informed consent unless it is performed for research purposes at the group level and with necessary ethical approval. The risk/benefit ratio of bioc
Maximize
发表于 2025-3-22 06:30:25
https://doi.org/10.1007/978-3-662-24745-7hers in lower tolerability. We discuss how this heterogeneity of treatment effect may lead to differential impacts of antihypertensive drugs on medication adherence among individual patients. We conclude by suggesting approaches to preventing adverse effects of antihypertensive drugs on medication a
猛然一拉
发表于 2025-3-22 10:46:37
http://reply.papertrans.cn/29/2831/283029/283029_5.png
AGGER
发表于 2025-3-22 15:32:48
https://doi.org/10.1007/978-3-662-24745-7e and avoid unnecessary treatment intensification. Given the expanding population with uncontrolled and resistant hypertension and emerging cost–benefits of adherence, addressing non-adherence to prescribed antihypertensive therapy is a top priority.
AGGER
发表于 2025-3-22 18:36:15
Adherence to Antihypertensive and Cardiovascular Preventive Treatment: The Contribution of the Lombadherence to statin treatment; and (4) there was a significant positive relationship between reduced adherence to treatment and increased risk of hospitalization for coronary disease, cerebrovascular disease, and heart failure. This was the case in younger and older patients, including those >85 year
folliculitis
发表于 2025-3-22 21:18:19
Directly Observed Therapy in Hypertension (DOT-HTN)ons and a maximum of 2 hours of post-DOT-HTN observation. Three reports had longer observation time, two of them with medication administration intervals, and blood pressure measurement intervals. Two were case reports, describing severe post-DOT-HTN adverse reactions, contributing with important sa
LURE
发表于 2025-3-23 04:03:36
http://reply.papertrans.cn/29/2831/283029/283029_9.png
法官
发表于 2025-3-23 05:33:01
http://reply.papertrans.cn/29/2831/283029/283029_10.png